Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
11/27/2002 | EP1259612A2 G-protein coupled receptor related polypeptides |
11/27/2002 | EP1259611A2 G-protein coupled receptors |
11/27/2002 | EP1259609A2 Human schizophrenia gene |
11/27/2002 | EP1259606A2 Compositions useful for regulating parkin gene activity |
11/27/2002 | EP1259595A2 Integrin antagonists |
11/27/2002 | EP1259547A2 High potency recombinant antibodies and method for producing them |
11/27/2002 | EP1259540A1 Nucleic acids, proteins, and antibodies |
11/27/2002 | EP1259531A2 Nucleic acids, proteins, and antibodies |
11/27/2002 | EP1259530A1 Melanoma differentiation associated gene - 5 and promoter and uses thereof |
11/27/2002 | EP1259527A1 35 human secreted proteins |
11/27/2002 | EP1259526A2 Nucleic acids, proteins, and antibodies |
11/27/2002 | EP1259525A1 Serine/threonine phosphatase polynucleotides, polypeptides, and antibodies |
11/27/2002 | EP1259251A2 Novel method for down-regulation of amyloid |
11/27/2002 | EP1259247A1 DNA ENCODING HUMAN ACID-SENSING ION CHANNEL BNaC4 (ASIC4) |
11/27/2002 | EP1259223A1 Protein matrix materials, devices and methods of making and using thereof |
11/27/2002 | EP1019504A4 Isoforms of the human vitamin d receptor |
11/27/2002 | EP0876500A4 Cold-active protease cp70 |
11/27/2002 | EP0700402B1 Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies |
11/27/2002 | EP0608261B1 Immunoreactive hepatitis c virus polypeptide compositions |
11/27/2002 | CN1382259A Improved method for detection of acid resistant microorganisms in stool |
11/27/2002 | CN1382216A DNA coding for beta-tubulin and use thereof |
11/27/2002 | CN1382214A Novel protein derived from agkistrodon saxatilis emelianov and process for preparing the same |
11/27/2002 | CN1382158A Multiple cytokine-antibody complexes |
11/27/2002 | CN1382153A 重组亚单位疫苗 Recombinant subunit vaccine |
11/27/2002 | CN1381500A Polypeptide-human macroprotien -49.61 and polynucleotide for coding it |
11/27/2002 | CN1381499A Polypeptide-human G protein coupling receptor -9.57 and polynucleotide for coding it |
11/27/2002 | CN1381498A Polypeptide-DNA bad damage repair protein -10.45 and polynucleotide for coding it |
11/27/2002 | CN1381497A Polypeptide-human macroprotein -64.79 and polynucleotide for coding it |
11/27/2002 | CN1381496A Polypeptide-human tyrosine kinase substrate-38.39 and polynucleotide for coding it |
11/27/2002 | CN1381495A Polypeptide-human myelin development regulation protein -35.86 and polynucleotide for coding it |
11/27/2002 | CN1381494A Polypeptide-human actin binding factor-46.31 and polynuceotide for coding it |
11/27/2002 | CN1381493A Polypeptide-human protein -9.9 containing uterus globulin function domain and polynucleotide for coding it |
11/27/2002 | CN1381492A Polypeptide-human rebosomal protein -8.91 and polynucleotide for coding it |
11/27/2002 | CN1381491A Polypeptide-human retinoic acid inducer protein -19.58 and polynucleotide for coding it |
11/27/2002 | CN1381490A Polypeptide-interferon inducer protein -32.34 and polynucleotide for coding it |
11/27/2002 | CN1381489A Polypeptide-human macroprotein-54.89 and polynucleotide for coding it |
11/27/2002 | CN1381488A Polypeptide-distal upstream element bindin 38.83 and polynucleotide for coding it |
11/27/2002 | CN1381487A Polypeptide-human protein-46.53 containing bromo structure domain and polynucleotide for coding it |
11/27/2002 | CN1381486A Polypeptide-human zinc finger protein-61.82 and polynucleotide for coding it |
11/27/2002 | CN1381485A Polypeptide-human macroprotein-27.28 and polynucelotide for coding it |
11/27/2002 | CN1381484A Polypeptide-human macroprotein-71.83 and polynucleotide for coding it |
11/27/2002 | CN1381483A Polypeptide-human sperm generation associated factor-86.90 and polynucleotide for coding it |
11/27/2002 | CN1381482A Polypeptide-clathrin light chain -9.02 and polynucleotide for coding it |
11/27/2002 | CN1381481A Polypeptide-human macroprotein -14.96 and polynucleotide for coding it |
11/27/2002 | CN1381480A Polypeptide-synapsin-9.57 and polynucleotide for coding it |
11/27/2002 | CN1381479A Polypeptide-human herpesvirus-23.43 and polynucleotide for coding it |
11/27/2002 | CN1381478A Polypeptide-ribosome S7 protein -11.77 and polynucleotide for coding it |
11/27/2002 | CN1381477A Polypeptide-human immunologlobulin light chain protein -26.40 and polynucleotide for coding it |
11/27/2002 | CN1381476A Polypeptide-human tumor endothelial marker -30.69 and polynucleotide for coding it |
11/27/2002 | CN1381475A Polypeptide-ribosomal protein L39-12.32 and polynucleotide for coding it |
11/27/2002 | CN1381474A Polypeptide-human nucleoporin -39.6 and polynucleotide for coding it |
11/27/2002 | CN1381473A Polypeptide-human macroprotein -46.53 and polynucleotide for coding it |
11/27/2002 | CN1381472A Polypeptide-replication protein A interactino protein alpha-24.09 and polynucleotide for coding it |
11/27/2002 | CN1381471A Polypeptide-human ferroheme Cu-ion respiration oxidase sub-unit-17.27 and polynucleotide for coding it |
11/27/2002 | CN1381470A Polypeptide-human Na-ion K-ion channel inhibitor-52.25 and polynucleotide for coding it |
11/27/2002 | CN1381469A Polypeptide-protein kinase 2 structure domain -23.43 and polynucleotide for coding it |
11/27/2002 | CN1381468A Polypeptide-human erythrocytic kytoplasma protein-8.8 and polynucleotide for coding it |
11/27/2002 | CN1381467A Polypeptide-human zinc finger protein-32.56 and polynucleotide for coding it |
11/27/2002 | CN1381465A Gene configuration, preparing process and usage of antibacterial peptide |
11/27/2002 | CN1094976C Tomato spotted wilt virus |
11/26/2002 | US6486305 Method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upf1p, eucaryotic release factor 1 and eucaryotic release factor 3 |
11/26/2002 | US6486131 As diagnostic and therapeutic assays and reagents for detecting and therapy of proliferative disorders arising from, for example, tumorigenic transformation of cells, or other hyperplastic or neoplastic transformation processes |
11/26/2002 | US6486123 Low oxygen affinity mutant hemoglobins |
11/26/2002 | US6485977 Recombinant constructs and techniques for delivering to eucaryotic cells bacterial proteins that are secreted via type III secretion systems |
11/26/2002 | US6485970 Immunointeractive antibody |
11/26/2002 | US6485968 Ectoparasite saliva proteins and apparatus to collect such proteins |
11/26/2002 | US6485960 Polycystic kidney disease 1 gene and uses thereof |
11/26/2002 | US6485957 DNA encoding the human serine protease EOS |
11/26/2002 | US6485936 Heat shock transcription factor-binding protein |
11/26/2002 | US6485935 Structure of the ankyrin binding domain of a α-Na, K-ATPase |
11/26/2002 | US6485934 Regulatory system for inducible expression of genes with lambdoid promoters |
11/26/2002 | US6485930 Mannosyl transfer with regeneration of GDP-mannose |
11/26/2002 | US6485919 Human metabotropic glutamate receptors, nucleic acids encoding same and uses thereof |
11/26/2002 | US6485914 Method of detecting chlamydia pneumoniae gene using polynucleotides |
11/26/2002 | US6485904 DNA encoding a plasminogen activating protein |
11/26/2002 | CA2228635C Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods |
11/26/2002 | CA2111573C Cadherin materials and methods |
11/26/2002 | CA2107672C Peptides and mixtures thereof for detecting antibodies to hepatitis c virus (hcv) |
11/26/2002 | CA2098838C Liver enriched transcription factor |
11/26/2002 | CA1341401C Immunosuppressant factor derived from human glioblastoma cells |
11/21/2002 | WO2002092842A2 Nucleic acids and corresponsing proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer |
11/21/2002 | WO2002092841A2 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon |
11/21/2002 | WO2002092832A2 Human and non-human primate homologues of nkd protein, nucleic acid sequences encoding, and uses thereof |
11/21/2002 | WO2002092829A1 Process for producing peptide |
11/21/2002 | WO2002092827A2 Corona-virus-like particles comprising functionally deleted genomes |
11/21/2002 | WO2002092819A1 A variable region of the monoclonal antibody against the hbv s-surface antigen and a gene encoding the same |
11/21/2002 | WO2002092812A1 ARTIFICIAL HUMAN CHROMOSOME CONTAINING HUMAN ANTIBODY μ LIGHT CHAIN GENE |
11/21/2002 | WO2002092801A2 Methods and compositions for making emamectin |
11/21/2002 | WO2002092782A2 Diagnosis and treatment of malignant neoplasms |
11/21/2002 | WO2002092771A2 Specific binding proteins and uses thereof |
11/21/2002 | WO2002092764A2 Transgenic animal model of bone mass modulation |
11/21/2002 | WO2002092762A2 Cytokine polypeptides |
11/21/2002 | WO2002092759A2 Molecules for disease detection and treatment |
11/21/2002 | WO2002092758A2 Gastrokines and derived peptides including inhibitors |
11/21/2002 | WO2002092625A2 Moraxella(branhamella) catarrhalis antigens |
11/21/2002 | WO2002092135A1 Methods of using labelled verotoxin b subunit |
11/21/2002 | WO2002092118A1 Global analysis of protein activities using proteome chips |
11/21/2002 | WO2002092004A2 Use of hmg fragment as anti-inflammatory agents |
11/21/2002 | WO2002092000A2 Hbm variants that modulate bone mass and lipid levels |
11/21/2002 | WO2002091995A2 Method to induce neovascular formation and tissue regeneration |